ZM336372, A Raf-1 Activator, Inhibits Growth of Pheochromocytoma Cells

This publication has 12 references indexed in Scilit:

• The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
  Anti-Cancer Drugs, 2006
• ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells
  Molecular Cancer Therapeutics, 2005
• The role of human achaete-scute homolog-1 in medullary thyroid cancer cells
  Surgery, 2003
• Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
• The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway
  Molecular and Cellular Biology, 2003
• Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation
  Surgery, 2002
• Morphological-Histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids
  Pathology and Oncology Research, 1999
• Paradoxical activation of Raf by a novel Raf inhibitor
  Chemistry & Biology, 1999
• The presence of K-12ras mutations in duodenal adenocarcinomas and the absence ofras mutations in other small bowel adenocarcinomas and carcinoid tumors
  Cancer, 1997
• Adrenocorticotropic hormone-secreting pheochromocytomas: The exception to the rule
  Surgery, 1995